DCADMA CAS 80944-06-5

Identification

CAS Number

80944-06-5

Name

DCADMA

Synonyms

Doxofylline Impurity 31
1,1-Dichloro-2,2-dimethoxyethane
Ethane, 1,1-dichloro-2,2-dimethoxy-
Dichloroacetaldehyde Dimethyl Acetal

SMILES

COC(C(Cl)Cl)OC

StdInChI

InChI=1S/C4H8Cl2O2/c1-7-4(8-2)3(5)6/h3-4H,1-2H3

StdInChIKey

NGVTXINFTCZHGA-UHFFFAOYSA-N

Molecular Formula

C4H8Cl2O2

Molecular Weight

159.01

Properties

Appearance

Clear Colorless to yellow Liquid

Safety Data

RIDADR 

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our DCADMA CAS 80944-06-5

Identification Methods

HNMR, GC, IR,MS

Purity

97% min

Shelf Life

1 year

Storage

Store at 2 to 8 °C temperature, tightly closed container

Known Application

Used as the Praziquantel impurity 6, Trichlorfon lmpurity 1 or Herbicide intermediate.

  1. Antibacterial/antistatic coatings and surface modifiers
    The quaternary ammonium salt structure gives it excellent antibacterial properties and can kill bacteria, fungi, and viruses; it can be introduced into coatings, films, gels, and fiber surfaces through copolymerization to form a long-lasting antibacterial layer; it is commonly used in medical devices, textile surface treatment, dental materials, contact lens surface modification, etc.
  2. Polymer modified monomers
    The dimethacrylate group allows it to copolymerize with free radicals such as acrylic acid and methacrylate resins; it is used to prepare functional polymer materials such as hydrogels, water treatment membranes, and conductive coatings; it has special applications in 3D printing, biomedical polymers, and hydrogel systems.
  3. Water treatment or membrane material additives
    The quaternary ammonium salt structure has ion exchange capacity and adsorption capacity for negatively charged pollutants; it can be used for anti-pollution modification of reverse osmosis membranes and flocculant structure construction; it improves the anti-pollution and hydrophilicity of the membrane and increases its service life.

General View of Documents

HNMR of DCADMA CAS 80944-06-5
HNMR of DCADMA CAS 80944-06-5
HNMR1 of DCADMA CAS 80944-06-5
HNMR1 of DCADMA CAS 80944-06-5
IR of DCADMA CAS 80944-06-5
IR of DCADMA CAS 80944-06-5
MS of DCADMA CAS 80944-06-5
MS of DCADMA CAS 80944-06-5
GC of DCADMA CAS 80944-06-5
GC of DCADMA CAS 80944-06-5

This product is developed by our R&D company Caming Pharmaceutical Ltd (https://www.caming.com/).

This product is developed by our R&D company Watson International Ltd (https://www.watson-int.com/).